Mawi DNA Technologies has signed a distribution agreement with Benta Group, a leader in the healthcare industry to deliver Mawi’s iSWAB biosampling technologies to the Middle East, Africa and Eastern Europe.
According to Bernard Tannoury, Chairman and CEO of Benta, the Group has partnered with Mawi because of the latter’s extensive experience in genomics and proteomics as well as its success in re-inventing biosampling.
We are excited about partnering with Benta, which will facilitate Mawi’s access to new markets and strengthen our presence in others” says Dr. Bassam El-Fahmawi, President & CTO of Mawi DNA Technologies.
Benta Group will be an authorized agent and distributor for Mawi products in the following countries Bahrain, Jordan, Kuwait, Oman, Iraq, Iran, Lebanon, Libya, Egypt, Morocco, Tunisia, Algeria, Nigeria, Congo, Angola, Equatorial Guinea, Ghana, Soudan, South Africa, Slovenia, Croatia, Bosnia, Serbia, Macedonia, Lithuania, Czech Republic and Russia.
About Benta Group:
Benta Group is a leader in the healthcare industry that responds to the market’s growing need for healthcare services, pharmaceutical products, medical devices, medical equipment and medical research.
Benta Group is present in more than 30 countries mainly in Lebanon, GCC countries, Egypt, France and the CIS market. For more information about Benta Group, please visit www.benta.com.lb
About Mawi DNA Technologies:
Mawi DNA Technologies was founded in 2013 and has developed and commercialized the iSWAB technology, an innovative system for collection of biosamples. The company’s flagship product iSWAB-DNA has gained significant market traction due to its ability to be utilized for animals and all human population segments from infants to elderly, robust DNA yield, and low bacterial DNA content. Mawi DNA Technologies has established relationships with well known children’s hospitals for neonatal screening, and has set up an extensive network of international distributors to market and sell iSWAB products globally. For more information, please visit our website at https://www.mawidna.com.
Alternative To Blood Samples Exome Sequencing Screening...
In a study published by the NPJ Genomic Medicine, Three young children presented with a neurodevelopmental disorder were studied to identify if there were pathogenic variants found in their ATG4D bi-...
READ MOREHigh-Efficiency Collection and Release Of Oral DNA Samples...
"The full release capacity functionality allows for adequate sample capture needed for DNA sample collection and processing." Mawi DNA Technologies, a medical device company fo...
READ MOREMeet The Mawi DNA Team We’ll be exhibiting at Booth…...
JOIN US AT ASHG | Nov 1-5, 2023 | Walter E. Washington Convention Center| Washington, D.C Mawi DNA Technologies improves the biological sample collection process with innovative technologies. Our ...
READ MORE
